Researchers introduced sialic-acid-binding immunoglobulin-like lectin (Siglec)-6 as a novel target for CAR T-cells in acute myeloid leukemia (AML) and found that Siglec-6 was prevalently expressed on AML cell lines and primary AML blasts, including the subpopulation of AML stem cells.
[Blood]
7992332
{7992332:YCAWDACM}
apa
50
1
164887
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
